Radiant Clinical Research, a network of wholly owned integrated clinical trial sites, has announced that Rebecca Little has joined the company as director of Business Development. In this role, she will focus on building relationships with emerging pharmaceutical and biotechnology companies, in addition to supporting Radiant’s ongoing initiatives.
Little brings nearly 10 years of business development experience to the role, including serving as the director of Business Development for a site network with more than 20 locations in the U.S. and Latin America. Prior to entering the field of clinical research, Little worked with autistic children administering Applied Behavioral Analysis (ABA) therapy. She holds a Bachelor of Science degree in Health Science from Clemson University.
“I am excited to join the Business Development team at Radiant,” said Little. “I learned about clinical trials while working as an ABA therapist, and I saw firsthand how clinical research can improve patient care. Radiant has created a blueprint for the trial process that produces high quality data and expedites the procedures needed to bring life-changing treatments to the public. I’m glad I get to help them expand their reach by securing new and innovative studies.”
Little will work alongside Casey Orvin, executive vice president of Business Development, and Amanda Rangel, senior director of Business Development. “We are thrilled to have Rebecca on our team,” said Orvin. “Her dedication to clinical research excellence is evidenced by the success she’s had in building relationships with trial sponsors and CROs throughout her career. She is a great fit for our organization.”